Mindray chairman completes share purchase ahead of schedule

Li Xiting, chairman and actual controller of Shenzhen Mindray Bio-Medical Electronics Co., Ltd., completed his plan to increase his shareholding in the company by RMB 200 million (including transaction fees) between November 27, 2025, and December 12, 2025. This preemptive completion of the six-month plan underscores his confidence in the company's future development and intrinsic value.

The chairman acquired a total of 1,005,381 shares through centralized bidding on the Shenzhen Stock Exchange, representing 0.08% of the company's total shares. This reached the maximum executable amount of his intended investment.

Following this transaction, Li Xiting now directly holds 1,005,381 shares. His total controlled shares, including those held indirectly through Smartco Development Limited and Magnifice (HK) Limited by himself and his concerted parties, increased to 625,028,716 shares, representing 51.55% of the company's total shares. This shareholding increase adheres to all relevant laws and regulations and will not affect the company's listing status or control structure.